Boehringer Ingelheim turnover in Hungary slips in 2012
German drugmaker Boehringer Ingelheim's turnover in Hungary edged down 0.6% to HUF 10.9 billion in 2012, managing director Gábor Zalai said at a press conference on Tuesday. Boehringer Ingelheim's market share came to 1.9%, making it the 17th biggest player. This year, the company expects sales to stagnate, Zalai said.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.